The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

Evidence of Benefit

Added a table titled Vaccine Efficacy of the FUTURE I and FUTURE II HPV Vaccine Trials.

Added text to state that it is important to recognize that composite endpoints were utilized as the primary endpoint in both of these trials, a substantial proportion of the cases were CIN 1 and 2 lesions, which are known to have a high likelihood of spontaneous resolution without medical intervention.

Back to Top

< Previous Section  |  Next Section >